[Hormonal contraception with subdermal implants (author's transl)].
D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D004467:Economics; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D016912:Levonorgestrel; D010060:Ovulation; D010342:Patient Acceptance of Health Care; D012102:Reproductive Control Agents; D012106:Research; D013672:Technology
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D012102:Reproductive Control Agents; D016912:Levonorgestrel
Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Effectiveness; Contraceptive Implants--side effects; Contraceptive Methods--side effects; Contraceptive Usage; Economic Factors; Evaluation; Family Planning; Levonorgestrel; Method Acceptability; Ovulation Suppression; Qualitative Evaluation; Reproductive Control Agents; Research And Development; Research Methodology; Studies; Technology; Use-effectiveness
Contraception hormonale par des implants sous-cutanes.